Sertoli cells, but not tumor cells, of seminoma in situ express ICAM-1

APMIS

Volumn 104, Issue 11, 1996, Pages 817-822

  Brændstrup, Otto ^a,b   Jensen, Leif ^a   Werdelin, Ole ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

ICAM 1; immune surveillance; seminoma; Sertoli cells

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSURVEILLANCE; PRIORITY JOURNAL; SEMINOMA; SERTOLI CELL; TUMOR CELL;

EID: 0029826079     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1996.tb04947.x     Document Type: Article

References (32)

1. Barker, C.F. & Billingham, R.E.: Immunologically privileged sites. Adv. Immunol. 25: 1-54. 1977.
2. Bell, D.A., Flotte, T.J. & Bhan, A.K.: Immunohistochemical characterization of seminoma and its inflammatory infiltrate. Hum. Pathol. 18: 511-520, 1987.
3. Bjorkman, P.J., Saper, M.A., Samraoui, B. et al.: The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 329: 512-518, 1987.
4. Braakman, E., Goedegebuure, P.S., Vreugdenhil, R.J. et al: ICAM - melanoma cells are relatively resistant to CD3-mediated T-cell lysis. Int. J. Cancer 46: 475-480, 1990.
5. Brændstrup, O., Moller M.L. & Werdelin, O.: Sertoli cells of intratubular germ cell neoplasia express beta-2-microglobulin. APMIS 103: 548-552, 1995.
6. Brændstrup, O.: HLA class I antigens are expressed by Sertoli cells of intratubular germ cell neoplasia. APMIS 104: 579-582, 1996.
7. Dustin, M.L. & Springer, T.A.: Lymphocyte function associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultivated endothelial cells. J. Cell Biol. 107: 321-331, 1988.
8. Elices, M.J., Osborn, L., Takada, Y. et al.: VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-1/fibronectin binding site. Cell 60: 577-584, 1990.
9. Elliot, B.E., Carlow, D.A., Rodricks, A.M. et al.: Perspectives on the role of MHC antigens in normal and malignant cell development. Adv. Cancer Res. 53: 181-245, 1989.
10. Griswold, M.D.: Interactions between germ cells and Sertoli cells in the testis. Biol. Reprod. 52: 211-216, 1995.
11. Haas, G.G., D'Cruz, O.J. & De Bault, L.E.: Distribution of human leukocyte antigen-ABC and -D/DR antigens in the unfixed human testis. Am. J. Reprod. Immunol. Microbiol. 18: 47-51, 1988.
12. Haas, W., Pereira, P. & Tonegawa, S.: Gamma/ delta Cells. Annu. Rev. Immunol. 11: 637-685, 1993.
13. Jacobsen, G.K. & Talerman, A.: Atlas of Germ Cell Tumours. Munksgaard, Copenhagen 1989.
14. Klein, G.: Immune and non-immune control of neoplastic development: Contrasting effects of host and tumor evolution. Cancer 45: 2486-2499, 1980.
15. Klein, B., Klein, T., Konichezky, M. et al.: The expression of HLA class I antigens in germ cell testicular cancer. Am. J. Clin. Pathol. 93: 202-207, 1990.
16. Kuhlmann, D., Dohr, G., Pusch, H.H. et al.: Absence of HLA class I and class II antigens as well as beta-2-microglobulin from normal and pathological spermatozoa. Tissue Antigens 27: 179-184, 1986.
17. Makgoba, M.W., Sanders, M.E., Ginther Luce, G.E. et al.: Functional evidence that intercellular adhesion molecule-1 (ICAM) is a ligand for LFA-1-dependent adhesion in T cell-mediated cytotoxicity. Eur. J. Immunol. 18: 637-640, 1988.
18. Nossal, G.J.V.: Negative selection of lymphocytes. Cell 76: 229-239.
19. Nouri, A.M.E., Hussain, R.F., Oliver, R.T.D. et al.: Immunological paradox in testicular tumours: The presence of a large number of activated T cells despite the complete absence of MHC antigens. Eur. J. Cancer 29A: 1895-1899, 1993.
20. Patarroyo, M. & Makgoba, M.W.: Leucocyte adhesion to cells. Scand. J. Immunol.: 30: 129-164, 1989.
21. Pöllänen, P. & Niemi, M.: Immunohistochemical identification of macrophages, lymphoid cells and HLA antigens in the human testis. Int. J. Androl. 10: 37-40, 1987.
22. Pober, J.S.: Cytokine-mediated activation of vascular endothelium. Am. J. Pathol. 113: 426-433, 1988.
23. Riccioli, A., Filippini, A., De-Cesaris, P. et al.: Inflammatory mediators increase surface of integrin ligands, adhesion to lymphocytes, and secretion of interleukin 6 in mouse Sertoli cells. Proc. Natl. Acad. Sci. USA 92: 5808-5812, 1995.
24. Shimizu, Y., Shaw, S., Graber, N., Venkat Gopal, T. et al.: Activation-independent binding of human memory T cells to adhesion molecule ELAM-1. Nature 349: 799-802, 1991.
25. Springer, T.A.: Adhesion receptors of the immune system. Nature 346: 425-434, 1990.
26. Takada, A., Ohmori, K., Takahashi, N. et al.: Adhesion of human cancer cells to vascular endothelium mediated by a carbohydrate antigen, sialyl Lewis A. Biochem. Biophys. Res. Comm. 179: 713-719, 1991.
27. Timmer, A., Oosterhuis, J.W., Koops, H.S. et al.: The tumor microenvironment: Possible role of integrins and the extracellular matrix in tumor biological behavior of intratubular germ cell neoplasia and testicular seminomas. Am. J. Pathol. 144: 1035-1044, 1994.
28. Tomita, Y., Kimura, M., Tanikawa, T. et al.: Immunohistochemical detection of intercellular adhesion molecule-1 (ICAM-1) and major histocompatibility complex class 1 antigens in seminoma. J. Urol. 149: 659-663, 1993.
29. Townsend, A., Ohlen, C., Bastin, J. et al.: Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 340: 443-448, 1989.
30. Vanky, F., Wang, P., Patarroyo, M. et al.: Expression of adhesion class I antigens on human tumor cells is required for their interaction with autologous lymphocytes in vitro. Cancer Immunol. Immunother. 31: 19-27, 1990.
31. x determinant on myeloid and tumor cells. Science 250: 1132-1135, 1990.
32. Zhao, X., Wei, Y.Q., Kariya, Y. et al.: Accumulation of gamma/delta T cells in human dysgerminoma and seminoma: Roles in autologous tumor killing and granuloma formation. Immunol. Invest. 24: 607-618, 1995.